Clinical Trial Update: Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 trial of dendritic cell vaccine therapy for advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: University of Pennsylvania | Conditions: Melanoma | Phase 1 | Status: COMPLETED